信号和神经退行性疾病的发病:潜在的治疗机会
Ilya Bezprozvanny1,2,3
1Laboratory of Molecular Neurobiology, Pavlov Institute of Physiology Russian Academy of Sciences, Saint Petersburg 199034, Russia mnlabspb@gmail.com bezprozvannyib@infran.ru.
粉样蛋白通路未能治疗神经退行性疾病. 探索假说,特别是使用SERCA调节器,为阿尔茨海默氏症和类似疾病提供了新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
背景情况:
- 阿尔茨海默病和其他神经退行性疾病对健康和经济造成重大负担.
- 目前的治疗策略主要针对粉样蛋白通路,但尚未产生有效的疾病修饰治疗方法.
研究的目的:
- 审查支持"神经退行症假说"作为替代治疗途径的证据.
- 为了解决信号调节的临床翻译挑战.
主要方法:
- 关于神经退行症的假设现有文献的综述.
- 讨论潜在的治疗药物,包括萨尔科内质网膜 (SERCA) 的正调节剂.
主要成果:
- 粉样蛋白通路在治疗神经退行性疾病方面表现出有限的成功.
- 对传统通道阻塞剂副作用的担忧阻碍了临床应用.
- 塞尔卡的正调节器是减轻副作用的潜在解决方案.
结论:
- 假说为神经退行性疾病提供了有希望的替代标.
- 塞尔卡调节器可以克服以前的安全问题,提供新的治疗线索.
- 需要进一步的临床试验来验证SERCA调节器在人类中的安全性和有效性.
更多相关视频
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
09:07Fluorescent Calcium Imaging and Subsequent In Situ Hybridization for Neuronal Precursor Characterization in Xenopus laevis
Published on: February 18, 2020
相关概念视频
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
